Sanggenol P exhibits significant anti-inflammatory and antioxidant properties, making it a promising candidate for therapeutic applications in chronic inflammatory diseases. It has been studied for its ability to inhibit key pro-inflammatory cytokines and suppress oxidative stress pathways, which may contribute to the protection of cells and tissues in conditions such as liver injury and neurodegenerative disorders. Additionally, Sanggenol P demonstrates anticancer activity by inducing apoptosis and inhibiting the proliferation of certain tumor cell lines. Its potential role in modulating signaling pathways involved in cell survival and death, such as NF-κB and MAPK, highlights its relevance in cancer research and drug development. Due to its natural origin and bioactive profile, Sanggenol P is also being explored for use in functional foods and nutraceuticals aimed at promoting cellular health and preventing age-related diseases.